Farmacotherapie bij kinderen: Kennislacunes in beeld gebracht

[Pharmacotherapy in Children: Identifying Knowledge Gaps]

Ineke van Beusekom, Ingrid Geesink, Mirjam van het Loo, James P. Kahan

ResearchPublished 2002

This study aims to identify which medications deserve priority for clinical research in the short term. The authors found that a lot of knowledge is already available and needs dissemination rather than further research. The medication for ADHD, Ritalin is the best example of this. However, many medications have not been studied yet in children and among those, two research questions are identified: 1 - clinical research on the safety, effectiveness and long term effects of (amongst others) psycho-active substances, new anti-epileptics and gastro-intestinal medications for use in children 2 - dissemination of knowledge on several medications to paediatricians, general practitioners and pharmacists.

Topics

Document Details

  • Copyright: RAND Corporation
  • Availability: Web Only
  • Year: 2002
  • Pages: 215
  • Document Number: MR-1585/2-CVZ

Citation

Chicago Manual of Style

van Beusekom, Ineke, Ingrid Geesink, Mirjam van het Loo, and James P. Kahan, Farmacotherapie bij kinderen: Kennislacunes in beeld gebracht: [Pharmacotherapy in Children: Identifying Knowledge Gaps]. Santa Monica, CA: RAND Corporation, 2002. https://www.rand.org/pubs/monograph_reports/MR1585z2.html.
BibTeX RIS

Research conducted by

The research described in this report was performed under the auspices of RAND Europe.

This publication is part of the RAND monograph report series. The monograph report was a product of RAND from 1993 to 2003. RAND monograph reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.